[go: up one dir, main page]

FI980488A - Uusi diagnostinen menetelmä - Google Patents

Uusi diagnostinen menetelmä

Info

Publication number
FI980488A
FI980488A FI980488A FI980488A FI980488A FI 980488 A FI980488 A FI 980488A FI 980488 A FI980488 A FI 980488A FI 980488 A FI980488 A FI 980488A FI 980488 A FI980488 A FI 980488A
Authority
FI
Finland
Prior art keywords
diagnostic method
new diagnostic
new
diagnostic
Prior art date
Application number
FI980488A
Other languages
English (en)
Swedish (sv)
Other versions
FI980488A0 (fi
Inventor
Maciej Krzysztof Kwiatkowski
Jonas Kurt Hugosson
Hans Lilja
Timo Loevgren
Kim Pettersson
Timo Piironen
Franz Helmut Richard Recker
Original Assignee
Arctic Partners Oy Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arctic Partners Oy Ab filed Critical Arctic Partners Oy Ab
Priority to FI980488A priority Critical patent/FI980488A/fi
Publication of FI980488A0 publication Critical patent/FI980488A0/fi
Priority to PCT/FI1999/000073 priority patent/WO1999045398A1/en
Priority to EP99902563A priority patent/EP1068534A1/en
Priority to JP2000534884A priority patent/JP2002506210A/ja
Publication of FI980488A publication Critical patent/FI980488A/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI980488A 1998-03-04 1998-03-04 Uusi diagnostinen menetelmä FI980488A (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI980488A FI980488A (fi) 1998-03-04 1998-03-04 Uusi diagnostinen menetelmä
PCT/FI1999/000073 WO1999045398A1 (en) 1998-03-04 1999-02-03 Method for differentiation of prostate cancer
EP99902563A EP1068534A1 (en) 1998-03-04 1999-02-03 Method for differentiation of prostate cancer
JP2000534884A JP2002506210A (ja) 1998-03-04 1999-02-03 前立腺ガンの識別方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980488A FI980488A (fi) 1998-03-04 1998-03-04 Uusi diagnostinen menetelmä

Publications (2)

Publication Number Publication Date
FI980488A0 FI980488A0 (fi) 1998-03-04
FI980488A true FI980488A (fi) 1999-09-05

Family

ID=8551117

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980488A FI980488A (fi) 1998-03-04 1998-03-04 Uusi diagnostinen menetelmä

Country Status (4)

Country Link
EP (1) EP1068534A1 (fi)
JP (1) JP2002506210A (fi)
FI (1) FI980488A (fi)
WO (1) WO1999045398A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI990382A0 (fi) * 1999-02-23 1999-02-23 Arctic Partners Oy Ab Uusi diagnostinen menetelmä
DE60127104D1 (de) * 2000-03-20 2007-04-19 Eastern Virginia Med School Prostatakrebs-marker
US20050037447A1 (en) * 2003-07-08 2005-02-17 Yong-Chuan Wong Protein markers for human benign prostatic hyperplasia (BPH)
US8663600B2 (en) * 2005-02-17 2014-03-04 Diaprost Ab Diagnosis of prostate cancer
CA3081061C (en) 2010-07-27 2023-01-03 Genomic Health, Inc. Method for using expression of klk2 to determine prognosis of prostate cancer
BR112014021776B1 (pt) 2012-03-05 2022-08-09 Opko Diagnostics, Llc Sistema de ensaio e método para a determinação de uma probabilidade de um evento associado com o câncer da próstata
DK3011059T3 (da) 2013-06-20 2019-05-13 Immunexpress Pty Ltd Biomarkør-identifikation
AU2015213486B2 (en) * 2014-02-06 2020-10-22 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
WO2015148979A1 (en) 2014-03-28 2015-10-01 Opko Diagnostics, Llc Compositons and methods related to diagnosis of prostate cancer
WO2016160545A1 (en) 2015-03-27 2016-10-06 Opko Diagnostics, Llc Prostate antigen standards and uses thereof
CN116242787A (zh) * 2023-03-07 2023-06-09 厦门大学 一种前列腺癌高特异性光谱检测方法与癌症判断装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614372A (en) * 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
GB2302874B (en) * 1995-06-29 1999-11-10 Orion Yhtymae Oy Novel proteins

Also Published As

Publication number Publication date
EP1068534A1 (en) 2001-01-17
WO1999045398A1 (en) 1999-09-10
JP2002506210A (ja) 2002-02-26
FI980488A0 (fi) 1998-03-04

Similar Documents

Publication Publication Date Title
IS8368A (is) Ný aðferð
DE69938817D1 (de) Erstellungsverfahren
ID26007A (id) Proses karbonilasi
NO20006207L (no) Overvåkningssystem
DE59907306D1 (de) Fadenchangierung
ID23316A (id) Proses karbonilasi
EP1124578A4 (en) NEW IMMUNOADJUVANTS
IS5106A (is) Ný aðferð
DE59908968D1 (de) Benzoylpyridazine
NO20003164L (no) Ultralydmetode
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
FI980488A (fi) Uusi diagnostinen menetelmä
FI991490A0 (fi) Visualisointimenetelmä
DE69919457D1 (de) Messtaster
ID28840A (id) Pengujian
FI990382A0 (fi) Uusi diagnostinen menetelmä
FI981431A0 (fi) Mittausmenetelmä
FI982722A0 (fi) Diagnostinen menetelmä
NO994317L (no) Diagnosemetode
FI982556A (fi) Sijainnin hallintamenetelmä
FI980950A0 (fi) Uusi diagnostinen menetelmä
FI981185A0 (fi) Uusi diagnostinen menetelmä
SE9800172D0 (sv) New method
SE9804191D0 (sv) New method
FI980165A0 (fi) Diagnostiskt foerfarande